EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis

Alireza Sheikhi, Navid Golchin, Masoud Sadeghi

Journal of Reports in Pharmaceutical Sciences · 06.10.2024 · 12 (1)

DOI: 10.5812/jrps-151774 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, online erschienen am 06.10.2024. Verfasst von Alireza Sheikhi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brachyury has recently garnered attention as both a biomarker and a causative factor in chordoma development, making it a promising therapeutic target.

Objectives

Herein, we report a systematic review and meta-analysis to evaluate brachyury as a diagnostic biomarker and therapeutic molecular target in chordomas.

Methods

Scopus, PubMed/Medline, Cochrane Library databases, and Web of Science were searched up to July 18, 2024, without any restrictions. The Comprehensive Meta-Analysis version 3.0 software was used to calculate the event rate (ER) with a 95% confidence interval (CI). We utilized STRING to explore functional interactions among the studied genes.

Results

Twenty-five studies related to the expression of brachyury and five related to the treatment vaccine of brachyury were included in this category. The ER of brachyury expression among chordoma patients was 92.2% (95% CI: 87.3% - 95.3%), with I² = 74.65%. Among the five studies related to treatment vaccines, there were three studies with Phase 1, one with Phase 2, and a case report.

Conclusions

The high expression suggests that brachyury serves as a reliable diagnostic marker for chordomas. The findings indicate potential therapeutic implications for targeting brachyury in chordoma treatment.

Zitieren

APA

Sheikhi, A., Golchin, N., & Sadeghi, M. (2024). Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis. Journal of Reports in Pharmaceutical Sciences, 12(1). https://doi.org/10.5812/jrps-151774

Vancouver

Sheikhi A, Golchin N, Sadeghi M. Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis. Journal of Reports in Pharmaceutical Sciences. 2024;12(1). doi:10.5812/jrps-151774

BibTeX
@article{Sheikhi2024,
  author = {Sheikhi, Alireza and Golchin, Navid and Sadeghi, Masoud},
  title = {Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis},
  journal = {Journal of Reports in Pharmaceutical Sciences},
  year = {2024},
  volume = {12},
  number = {1},
  doi = {10.5812/jrps-151774}
}
Kostenlos starten →